Gadolinium contrast agents in MRI : clinical and economic considerations. Symposium - Gadalinium contrast agents in MRI : clinical and economic considerations. Symposium. New York NY (USA) ; Los Angeles CA (USA), 1992/02/29 - 1992/03/04.
Implementation of an accurate, reliable index of cost effectiveness would help to advance technology assessment and reimbursement of MR imaging procedures, including gadolinium enhancement.
To this end, an objective, consensual measure that satisfies the need for « gold-standard » confirmation of diagnostic impressions in routine clinical practice and limits interpreter bias has been developed.
Eponymously termed Diagnostic Merit, this barometer is expressed as the percentage of independent judges confirming diagnostic impressions entered by case-blinded radiologists assigned unenhanced and enhanced image sets for interpretation.
Mots-clés Pascal : Imagerie RMN, Analyse coût efficacité, Economie santé, Agent contraste paramagnétique, Gadolinium Complexe, Diagnostic, Evaluation performance, Remboursement
Mots-clés Pascal anglais : Nuclear magnetic resonance imaging, Cost efficiency analysis, Health economy, Paramagnetic contrast agent, Gadolinium Complexes, Diagnosis, Performance evaluation
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0519425
Code Inist : 002B24A10. Création : 199406.